Nasdaq Rallies on U.S. Data, But Some Say It Won't Last

Article Abstract:

The Nasdaq finished with the best week ever yet investors are skeptical.

Other Financial Vehicles, Securities prices, Security & commodity services, not elsewhere classified, Stock Quotation Services, The Nasdaq Stock Market Inc.

---

Oil could slip up stock gains

Article Abstract:

Petroleum securities rose on the strength of soaring oil prices in 2004. As the majority of the stock market stumbles, petroleum securities have soared this year.

Sales & consumption, Crude Petroleum and Natural Gas Extraction, Crude petroleum and natural gas, Crude Petroleum & Natural Gas, Securities issued, listed, Petroleum refining, Analysis, Petroleum industry, Securities, Company securities, Industry sales and revenue

---

Sharp decline in stocks reflects investors' greater aversion to risk

Article Abstract:

Securities investors are retreating from high risk investments as the United States economy seems to be slowing. Some companies are experiencing slower growth, consumer spending is down and fears of high oil prices are mitigating factors. Economic indicators are down and the United States Federal Reserve has new concerns over inflation.

Forecasts, trends, outlooks, Labor Distribution by Employer, Economic aspects, Statistics, Economic indicators, Global economy, Industry forecasts

Similar abstracts:

• Abstracts: Legardere to invest 1.07 billion euros to expand its television interests. Vivendi unveils merger, knocking shares lower
• Abstracts: Star bid for NCL could stuble as investment firm enters fray. Carnival to acquire remaining 50% of Costa Crociere
• Abstracts: Crude calculation: awash in a gusher of cash, oil firms are reluctant investors. TotalFina-Elf sees further synergies from its mergers
• Abstracts: Reuters revenue increased 7.9% in first quarter in Instinet growth. Reuters swings back to profit, but warns on 2004 revenue
• Abstracts: AstraZeneca, Aventis Post Strong Drug Sales. Results at Firms' Agrochemical Units Contrast. Glaxo Wellcome's 1st-half net jumped 19% on strong sales

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.